CAROLINE BROWN: Open Payments
NPI 1407815384 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,302 in 107 payments from 19 companies in 2025. Trend: 2023 $3,043 · 2024 $2,609 · 2025 $2,302
Food & beverage: $2,155Education: $147
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $372 |
| Janssen Biotech, Inc. | 9 | $275 |
| UCB, Inc. | 10 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $229 |
| Regeneron Healthcare Solutions, Inc. | 4 | $211 |
| Galderma Laboratories, L.P. | 15 | $190 |
| GENZYME CORPORATION | 10 | $146 |
| Incyte Corporation | 3 | $132 |
| Amgen Inc. | 5 | $114 |
| PFIZER INC. | 4 | $87 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, RINVOQ, NEMLUVIO, OPZELURA, Leqselvi.
Industry payments across SC — which companies pay providers there.
